€5,000,000,000 Limited Recourse Secured Note Programme
€5,000,000,000 Limited Recourse Secured Note Programme
€5,000,000,000 Limited Recourse Secured Note Programme
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ISSUER ADDENDUM<br />
<strong>€5</strong>,<strong>000</strong>,<strong>000</strong>,<strong>000</strong><br />
<strong>Limited</strong> <strong>Recourse</strong> <strong>Secured</strong> <strong>Note</strong> <strong>Programme</strong><br />
Ashwell Rated S.A.<br />
(a public limited liability company (société anonyme) incorporated under the laws of the Grand Duchy of Luxembourg, having its<br />
registered office at Carré Bonn, 20, rue de la Poste, L-2346 Luxembourg and registered with the Luxembourg trade and companies<br />
register under number B. 107.848 and subject as an unregulated undertaking to the Luxembourg act dated 22 March 2004 on<br />
securitisation)<br />
This Issuer Addendum (the Issuer Addendum) in respect of Ashwell Rated S.A. (the Issuer or Ashwell<br />
Rated) has been prepared for the purpose of giving information about Ashwell Rated and incorporates by<br />
reference pages 1 to 194 (inclusive) of the base prospectus dated 22 November 2007 in relation to the<br />
<strong>€5</strong>,<strong>000</strong>,<strong>000</strong>,<strong>000</strong> <strong>Limited</strong> <strong>Recourse</strong> <strong>Secured</strong> <strong>Note</strong> <strong>Programme</strong> (the <strong>Programme</strong>) under which the Issuer issues<br />
<strong>Note</strong>s (the <strong>Note</strong>s) or, subject to restrictions of the Securitisation Act 2004, enters into loans (the Loans) from<br />
time to time, and comprises a base prospectus (the Base Prospectus) in respect of Ashwell Rated for the<br />
purposes of Article 5.4 of the Directive 2003/71/EC (the Prospectus Directive). This Issuer Addendum<br />
forms part of the Base Prospectus and incorporates by reference the rest of the Base Prospectus and all other<br />
documents which are deemed to be incorporated by reference in the Base Prospectus. The Issuer acceded to<br />
the <strong>Programme</strong> pursuant to a deed of adherence (the Deed of Adherence) dated 19 May 2005 between inter<br />
alia the Issuer and the Trustee. Unless the context otherwise requires, terms defined in the Base Prospectus<br />
shall have the same meaning when used in this Issuer Addendum.<br />
Application has been made to the Irish Financial Services Regulatory Authority, as competent authority<br />
under the Prospectus Directive 2003/71/EC, for the Base Prospectus to be approved. Such approval relates<br />
only to the <strong>Note</strong>s which are to be admitted to trading on the regulated market of the Irish Stock Exchange or<br />
other regulated markets for the purposes of Directive 2004/39/EC or which are to be offered to the public in<br />
any Member State or the European Economic Area. Application has been made to the Irish Stock Exchange<br />
for the <strong>Note</strong>s to be admitted to the Official List and trading on its regulated market.<br />
The Issuer accepts responsibility for the information contained in the Base Prospectus having taken all<br />
reasonable care to ensure that such is the case, the information contained in the Base Prospectus is, to the<br />
best of its knowledge, in accordance with the facts and does not omit anything likely to affect its import.<br />
The delivery of this Issuer Addendum at any time does not imply that any information contained herein is<br />
correct at any time subsequent to the date hereof.<br />
The information included in the applicable Series Prospectus with respect to the Charged Assets, the<br />
Reference Entity (or Reference Entities, as the case may be) and the Reference Obligations (in each case as<br />
applicable) will be accurately reproduced and as far as the Issuer is aware and is able to ascertain from the<br />
information published by any third party, no facts will have been omitted which would render the reproduced<br />
information inaccurate or misleading. No further or other responsibility in respect of such information is<br />
accepted by the Issuer.<br />
No person is or has been authorised by the Issuer to give any information or to make any representation not<br />
contained in or not consistent with this Issuer Addendum or any supplement or any other information<br />
supplied in connection with the <strong>Programme</strong> or the <strong>Note</strong>s and, if given or made, such information or<br />
representation must not be relied upon as having been authorised by the Issuer, the Trustee or Bear, Stearns<br />
International <strong>Limited</strong> as Arranger (the Arranger) or the relevant Dealer.<br />
1
Purchasers of <strong>Note</strong>s should conduct such independent investigation and analysis regarding the Issuer, the<br />
security arrangements (including, without limitation, with regard to any obligor of the Charged Assets, any<br />
Reference Entity, any Swap Counterparty, any Swap Guarantor, any Credit Support Provider and any Issuer<br />
Credit Enhancer and the full terms of the Charged Assets, Reference Obligations and the Charged<br />
Agreement(s) (in each case as applicable)) and the <strong>Note</strong>s as they deem appropriate to evaluate the merits and<br />
risks of an investment in the <strong>Note</strong>s. None of the Trustee, the Dealers or the Arranger have or will have<br />
separately verified the information contained herein. Accordingly, no representation, warranty or<br />
undertaking, express or implied, is or will be made and no responsibility or liability is or will be accepted by<br />
the Trustee, the Dealers or the Arranger as to the accuracy or completeness of the information contained in<br />
this Issuer Addendum or in any other information provided by the Issuer in connection with the <strong>Programme</strong><br />
or the <strong>Note</strong>s or their distribution and none of the Trustee, the Dealer or the Arranger accepts any liability<br />
therefor. The statements made in this paragraph are made without prejudice to the responsibility of the<br />
Issuer under the <strong>Programme</strong>.<br />
This Issuer Addendum does not constitute, and may not be used for the purposes of, an offer or solicitation<br />
by anyone in any jurisdiction in which such offer or solicitation is not authorised or to any person to whom it<br />
is unlawful to make such offer or solicitation, and no action is being taken which would permit an offering of<br />
the <strong>Note</strong>s or the distribution of the Base Prospectus or any Series Prospectus in any jurisdiction where action<br />
for such purpose is required.<br />
The only assets of the Issuer available to meet the claims of the <strong>Note</strong>holders of any Series will be the<br />
assets secured in respect of that Series.<br />
Arranger<br />
Bear, Stearns International <strong>Limited</strong><br />
Dealers<br />
Bear, Stearns International <strong>Limited</strong> Bear, Stearns & Co. Inc.<br />
Bear Stearns Bank plc<br />
The date of this Issuer Addendum is 22 November 2007<br />
2
Neither this Issuer Addendum nor other information supplied in connection with the <strong>Programme</strong> or the <strong>Note</strong>s<br />
(i) is intended to provide the basis of any credit or other evaluation or (ii) should be considered as a<br />
recommendation or as constituting an invitation or offer by any Issuer, the Trustee or any of the Dealers that<br />
any recipient of this Issuer Addendum or other information supplied in connection with the <strong>Programme</strong> or<br />
any <strong>Note</strong>s should purchase any <strong>Note</strong>s. Each investor contemplating purchasing any <strong>Note</strong>s should make its<br />
own independent investigation of the financial condition and affairs, and its own appraisal of the<br />
creditworthiness, of the Issuer, the relevant Swap Counterparty (if any), the relevant Issuer Credit Enhancer<br />
(if any), the relevant Credit Support Provider (if any), the relevant Swap Guarantor (if any), the Reference<br />
Entit(y/ies) (if any), the obligor under the relevant Charged Assets and the past and possible future<br />
performance of any relevant index or security (see the section entitled "Risk Factors" on page 6 for a<br />
discussion of certain factors to be considered in connection with an investment in the <strong>Note</strong>s). Neither this<br />
Issuer Addendum nor any other information supplied in connection with the <strong>Programme</strong> or any <strong>Note</strong>s<br />
constitutes an offer or invitation by or on behalf of any Issuer or any of the Dealers to any person to<br />
subscribe for or to purchase any <strong>Note</strong>s.<br />
The delivery of the Base Prospectus or any Series Prospectus or the offering, sale or delivery of any <strong>Note</strong>s<br />
shall not at any time or in any circumstances imply that the information contained herein or therein<br />
concerning the Issuer is correct at any time subsequent to the date hereof or thereof (as the case may be) or<br />
that any other information supplied in connection with the <strong>Programme</strong> is correct as of any time subsequent to<br />
the date indicated in the document containing the same. The Trustee, the Arranger and the Dealers expressly<br />
do not undertake to review the financial condition or affairs of the Issuer, any Swap Counterparty, any Issuer<br />
Credit Enhancer, any Credit Support Provider, any Swap Guarantor, any Reference Entity or any obligor<br />
under any Charged Assets during the life of the <strong>Programme</strong>. Investors should review, inter alia, the most<br />
recent financial statements, (if any), of the Issuer, the relevant Swap Counterparty (if any), the relevant<br />
Issuer Credit Enhancer (if any), the relevant Credit Support Provider (if any), the relevant Swap Guarantor<br />
(if any), the Reference Entity(ies) (if any) and any obligor under the relevant Charged Assets when deciding<br />
whether or not to purchase any <strong>Note</strong>s.<br />
The Base Prospectus or any Series Prospectus does not constitute an offer to sell or the solicitation of an<br />
offer to buy any <strong>Note</strong>s in any jurisdiction to any person to whom it is unlawful to make the offer or<br />
solicitation in such jurisdiction. The distribution of the Base Prospectus or any Series Prospectus and the<br />
offer or sale of <strong>Note</strong>s may be restricted by law in certain jurisdictions. The Issuer, the Trustee, the Arranger<br />
and the Dealers do not and will not represent that the Base Prospectus or any Series Prospectus may be<br />
lawfully distributed, or that the <strong>Note</strong>s may be lawfully offered, in compliance with any applicable<br />
registration or other requirements in any such jurisdiction, or pursuant to an exemption available thereunder,<br />
or assume any responsibility for facilitating any such distribution or offering. In particular, no action has<br />
been or will be taken by the Issuer, the Trustee, the Arranger or the Dealers which would permit a public<br />
offering of the <strong>Note</strong>s or distribution of the Base Prospectus or any Series Prospectus in any jurisdiction<br />
where action for that purpose is required. Accordingly, the <strong>Note</strong>s may not be offered or sold, directly or<br />
indirectly, and neither the Base Prospectus or any Series Prospectus nor any advertisement or other offering<br />
material may be distributed or published in any jurisdiction, except under circumstances that will result in<br />
compliance with any applicable laws and regulations. Persons into whose possession the Base Prospectus or<br />
any Series Prospectus or <strong>Note</strong>s come must inform themselves about, and observe, any such restrictions. In<br />
particular, there are restrictions on the distribution of the Base Prospectus or any Series Prospectus and the<br />
offer or sale of <strong>Note</strong>s in the United States (or to or for the account or benefit of U.S. persons), the European<br />
Economic Area (including the United Kingdom, the Grand Duchy of Luxembourg, Germany, the Republic<br />
of Italy, Spain, The Netherlands, Belgium and France), Japan and the Cayman Islands (see the section<br />
entitled "Subscription and Sale and Transfer Restrictions" in the Base Prospectus).<br />
Circular 230 Notice<br />
To ensure compliance with U.S. Treasury Department regulations, we advise you that any tax discussion<br />
herein was not written and is not intended to be used and cannot be used by any taxpayer for purposes of<br />
avoiding U.S. federal income tax penalties that may be imposed on the taxpayer. Any such tax discussion<br />
was written to support the promotion or marketing of the <strong>Note</strong>s to be issued pursuant to the Base Prospectus.<br />
3
Each taxpayer should seek advice based on the taxpayer's particular circumstances from an independent tax<br />
advisor.<br />
Notwithstanding any provision herein and the otherwise confidential nature of this Issuer Addendum and its<br />
contents, and effective from the date of commencement of discussions concerning the transaction described<br />
or contemplated hereby, each party to such transactions (and each employee, representative, or other agent of<br />
such party) may disclose to any and all persons, without limitation of any kind, the tax treatment and tax<br />
structure of the transactions and all materials of any kind (including opinions or other tax analyses) that are<br />
provided to it relating to such tax treatment and tax structure, except to the extent that any such disclosure<br />
could reasonably be expected to cause the transactions not to be in compliance with securities laws. In<br />
addition, no person may disclose the name of or identifying information with respect to any party identified<br />
herein or other non-public business or financial information that is unrelated to the tax treatment or tax<br />
structure of the transactions without the prior consent of the Issuer. For the purposes of this paragraph, the<br />
tax treatment of the transactions is the purported or claimed U.S. federal income tax treatment of the<br />
transactions, and the tax structure of the transactions is any fact that may be relevant to understanding the<br />
purported or claimed U.S. federal income tax treatment of the transactions.<br />
4
Table of Contents<br />
Risk Factors .........................................................................................................................................6<br />
Documents Incorporated by Reference..................................................................................................13<br />
Ashwell Rated S.A. ..............................................................................................................................14<br />
General Information .............................................................................................................................17<br />
5
RISK FACTORS<br />
The purchase of <strong>Note</strong>s may involve substantial risks and is suitable only for sophisticated investors who have<br />
the knowledge and experience in financial and business matters necessary to enable them to evaluate the<br />
risks and the merits of an investment in the <strong>Note</strong>s.<br />
The Issuer believes that the following factors may be relevant to it and its industry. All of these factors are<br />
contingencies which may or may not occur and the Issuer is not in a position to express a view on the<br />
likelihood of any such contingency occurring.<br />
The Issuer believes that the factors described below represent the principal risks inherent in investing in<br />
<strong>Note</strong>s issued under the <strong>Programme</strong>, but the inability of the Issuer to pay interest, principal or other amounts<br />
on or in connection with any <strong>Note</strong>s may occur for other reasons and such Issuer does not represent that the<br />
statements below regarding the risks of holding any <strong>Note</strong>s are exhaustive. Prospective investors should also<br />
read the detailed information set out in the Base Prospectus and the relevant Series Prospectus and, in the<br />
light of their own financial circumstances and investment objectives, reach their own views prior to making<br />
any investment decision.<br />
Securitisation Act 2004 and Compartments<br />
The Issuer is established as a société de titrisation within the meaning of the Luxembourg act dated 22<br />
March 2004 on securitisation (the Securitisation Act 2004). The Issuer is not a regulated undertaking and is<br />
not subject to the supervision of the Luxembourg financial sector and stock exchange regulator, the CSSF.<br />
Pursuant to the Securitisation Act 2004, claims against the Issuer by holders of each Series of <strong>Note</strong>s will be<br />
limited to the net assets of the relevant Series included in the relevant compartment within the meaning of<br />
article 62 of the Securitisation Act 2004 (the Compartment). The board of directors of the Issuer (the<br />
Board) may establish one or more Compartments each of which is a separate and distinct part of the Issuer’s<br />
estate (patrimoine) and which may be distinguished by the nature of acquired risks or assets, the Conditions<br />
of the <strong>Note</strong>s issued in relation to the Compartment, the reference currency or other distinguishing<br />
characteristics. The Conditions relating to the <strong>Note</strong>s issued in respect of, and the specific objects of, each<br />
Compartment shall be determined by the Board. Each holder of <strong>Note</strong>s issued by the Issuer shall be deemed<br />
to fully adhere to, and be bound by, the Conditions and the articles of incorporation of the Issuer (the<br />
Articles).<br />
Subject to any particular rights or limitations for the time being attached to any <strong>Note</strong>s, as may be specified in<br />
the Articles or upon which such <strong>Note</strong>s may be issued including, without limitation, the Conditions, if a<br />
Compartment is liquidated its assets shall be applied in the order set out in the Conditions.<br />
As set out above, each Compartment corresponds to a separate and distinct part of the Issuer's estate<br />
(patrimoine). The rights of holders of <strong>Note</strong>s issued in respect of a Compartment and the rights of creditors<br />
are limited to the assets of that Compartment, where these rights relate to that Compartment or have arisen at<br />
the occasion of the constitution, the operation or the liquidation of the relevant Compartment. The assets of a<br />
Compartment are exclusively available to satisfy the rights of holders of <strong>Note</strong>s issued in relation to that<br />
Compartment and the rights of creditors whose claims have arisen at the occasion of the constitution, the<br />
operation or the liquidation of that Compartment.<br />
In the relationship between the holders of <strong>Note</strong>s of different Series, each Compartment is deemed to be a<br />
separate entity.<br />
Fees, expenses and other liabilities incurred on behalf of the Issuer as a whole shall, unless otherwise<br />
determined by the Board, be general liabilities of the Issuer and shall not be payable out of the assets of any<br />
Compartment. The Board shall endeavour, to the extent possible (although there is no guarantee that the<br />
Board will be able to achieve this), that creditors of such liabilities waive recourse to the assets of any<br />
Compartment.<br />
6
The Board shall establish and maintain separate accounting records for each of the Compartments of the<br />
Issuer for the purposes of ascertaining the rights of holders of <strong>Note</strong>s issued in respect of each Compartment<br />
for the purposes of the Articles and the Conditions of the <strong>Note</strong>s, such accounting records being conclusive<br />
evidence of such rights in the absence of proven manifest error.<br />
The assets of each Compartment (the Series Assets) may include the proceeds of the issue of the <strong>Note</strong>s of<br />
the relevant Series of <strong>Note</strong>s, the relevant Charged Assets and Mortgaged Property and any Charging<br />
Document or Charged Agreement. The fees, costs and expenses in relation to the <strong>Note</strong>s of each Series are<br />
allocated to the Compartment relating to the relevant Series in accordance with the Conditions and the<br />
Articles. <strong>Note</strong>holders of a Series will have recourse only to the Series Assets relating to the relevant Series.<br />
The rights of all holders of a Series will be restricted to the Series Assets for such Series regardless of how<br />
many Tranches of <strong>Note</strong>s or Classes of <strong>Note</strong>s are comprised within such Series.<br />
Pursuant to the Securitisation Act 2004, the proceeds of the Series Assets for each Series are available for<br />
distribution only to the specified <strong>Note</strong>holders and the creditors (including, but not limited to, the Trustee and<br />
any Swap Counterparty) relating to such Series (each such party, a Series Party). A creditor of the Issuer<br />
may have claims against the Issuer in respect of more than one Series, in which case the claims in respect of<br />
each Series will be limited to the Series Assets relating to such Series only.<br />
The right of <strong>Note</strong>holders of any Series issued in respect of, and allocated to, each Compartment to participate<br />
in the assets of the Issuer is limited to the Series Assets relating to such Series. If the payments received by<br />
the Issuer in respect of the Series Assets are not sufficient to make all payments due in respect of the <strong>Note</strong>s,<br />
the obligations of the Issuer in respect of the relevant Series of <strong>Note</strong>s will be limited to the Series Assets of<br />
the Compartment in respect of that Series, as specified in the Conditions and the relevant Series Prospectus<br />
(if any). The Issuer will not be obliged to make any further payment for any Series of <strong>Note</strong>s in excess of the<br />
amounts received upon the realisation of the Series Assets for the relevant Compartment. Following the<br />
application of the proceeds of realisation of the relevant Series Assets in accordance with the Conditions, the<br />
claims of the <strong>Note</strong>holders, the hedging counterparties (if any) and any other Series Parties for any shortfall<br />
shall be extinguished and the <strong>Note</strong>holders, the hedging counterparties (if any) and the other Series Parties<br />
(and any person acting on behalf of any of them) may not take any further action to recover such shortfall.<br />
In particular, no such party will be able to petition for the winding-up of the Issuer. Failure to make payment<br />
in respect of any shortfall shall in no circumstances constitute an Event of Default under the Conditions. Any<br />
shortfall shall be borne by the <strong>Note</strong>holders, each hedging counterparty (if any) and any other Series Party of<br />
the relevant Series in respect of which the <strong>Note</strong>s have been issued according to the priorities specified in the<br />
Conditions of the <strong>Note</strong>s.<br />
To give effect to the provisions of the Securitisation Act 2004 under which the Series Assets of a<br />
Compartment are available only for the Series Parties for the relevant Series relating to that Compartment,<br />
the Issuer will seek to contract with parties on a "limited recourse" basis such that claims against the Issuer<br />
would be restricted to the Series Assets of the Compartment for the relevant Series.<br />
No party will be able to attach or otherwise seize the assets of the Issuer allocated to the relevant<br />
Compartment or to other compartments of the Issuer or other assets of the Issuer.<br />
However, there is no guarantee that the Issuer will be able to contract on a limited recourse basis with respect<br />
to all agreements that the Issuer may from time to time enter into in relation to any particular Tranche, Class<br />
or Series and there may be creditors whose claims are preferred by law. In such circumstances, the Series<br />
Assets relating to one or more Compartments may be subject to claims by creditors other than the relevant<br />
Series Parties for the relevant Series resulting in a shortfall in the amounts available to meet the claims of the<br />
relevant Series Parties.<br />
7
Allocation of Shortfalls Among Classes or Tranches of a Series<br />
The Issuer expects from time to time to make issues of <strong>Note</strong>s in different Series, each comprising one or<br />
more Classes or Tranches. The assets secured for each Class or Tranche within a Series will not be held in a<br />
separate Compartment (and therefore will not be deemed to be separate from one another).<br />
Each Class or Tranche of a Series will represent a separate class or tranche of <strong>Note</strong>s and each Series will<br />
have Series Assets relating to that Series. The relevant Series Assets will be available to meet all the<br />
liabilities of the relevant Series, regardless of the different amounts stated to be payable on the separate<br />
Tranches (as set out in the relevant Series Prospectus).<br />
In practice, cross liability between Classes or Tranches is only likely to arise where the aggregate amounts<br />
payable in respect of any Class or Tranche (expected to be the redemption amount and any interest which<br />
may be payable in accordance with the Conditions applicable to that Class or Tranche) exceed the relevant<br />
Series Assets notionally allocated to that Class or Tranche (that is, those amounts (if any) received by the<br />
Issuer under the relevant Charged Assets and Mortgaged Property and Charging Document(s) and Charged<br />
Agreement(s) and any other assets comprising the relevant Series Assets after payment of all fees, costs,<br />
expenses and other liabilities which are to be borne by the relevant Series Assets and which rank before the<br />
holders of the relevant <strong>Note</strong>s) that are intended to fund payments in respect of such Class or Tranche or are<br />
otherwise attributable to that Class or Tranche. In these circumstances, the remaining Series Assets<br />
notionally allocated to any other Class or Tranche of the same Series may be available to meet such<br />
payments and may accordingly not be available to meet any amounts that otherwise would have been<br />
payable on such other Class or Tranche.<br />
Allocation of Liabilities among all <strong>Note</strong>holders<br />
Any liability which is not a Series-specific liability (that is, any liability that does not relate to the<br />
Compartment in respect of which the Series is issued) which is not otherwise funded will be apportioned<br />
between the Series Assets of all the <strong>Note</strong>s pro rata to the amounts owing on such <strong>Note</strong>s. The apportionment<br />
of such liability will reduce the return that would otherwise have been payable on such <strong>Note</strong>s. The Issuer<br />
will seek to contract with all counterparties on a limited recourse basis such that claims in respect of any<br />
liability which is not Series-specific may not be made in respect of the Series Assets of any Compartment.<br />
However, any creditor who has not contracted with the Issuer on a limited recourse basis (or any creditor<br />
with claims preferred by law, as the case may be) may make a claim against the Series Assets of a<br />
Compartment and such claim could affect the amount of Series Assets available to meet the obligations of<br />
the Issuer to the relevant <strong>Note</strong>holders and the other Series Parties.<br />
Consequences of Winding-up Proceedings<br />
If the Issuer fails, for any reason, to meet its obligations or liabilities (for instance, if the Issuer is unable to<br />
pay its debts and may obtain no further credit), a creditor may be entitled to make an application for the<br />
commencement of insolvency proceedings against the Issuer. The commencement of such proceedings may<br />
involve certain conditions, entitle creditors (including hedging counterparties) to terminate contracts with the<br />
Issuer (including hedging agreements) and claim damages for any loss arising from such early termination.<br />
The commencement of such proceedings may result in the Issuer's assets (including the Series Assets of all<br />
the Series) being realised and applied to pay the fees and costs of the liquidator, debts preferred by law and<br />
debts payable in insolvency, before any surplus is distributed to the <strong>Note</strong>holders. In the event of proceedings<br />
being commenced, the Issuer may not be able to pay the full redemption amount or any amount of interest,<br />
and any other or alternative amounts anticipated by the Conditions in respect of any Class or Tranche or<br />
Series of <strong>Note</strong>s. The Issuer will seek to contract only with parties who agree not to make application for the<br />
winding-up, liquidation or bankruptcy of the Issuer or any similar insolvency related proceedings.<br />
<strong>Limited</strong> recourse<br />
(A) The rights of <strong>Note</strong>holders of any Series issued in respect of, and allocated to, each Compartment to<br />
participate in the assets of the Issuer is limited to the Series Assets relating to each Series. All<br />
8
payments to be made by the Issuer in respect of the <strong>Note</strong>s, Receipts and Coupons of each Series and<br />
the relative Swap Agreement (if any) will be made only from and to the extent of the sums received<br />
or recovered from time to time by or on behalf of the Issuer or the Trustee in respect of (i) the<br />
relative Charged Assets and the relative Credit Support Document(s) and (ii) in the case of the<br />
<strong>Note</strong>s, Receipts and Coupons of each Series, the other Mortgaged Property (as defined in Condition<br />
3(a) (Security - Security)) in respect of such Series (applied, if applicable, in accordance with the<br />
ranking of the Classes within such Series);<br />
(B) To the extent that such sums are less than the amount which the holders of the <strong>Note</strong>s, Receipts and<br />
Coupons and such Swap Counterparty (if any) may have expected to receive if paragraph (A) above<br />
did not apply (the difference being referred to herein as a "shortfall"), such shortfall will be borne by<br />
such holders and by such Swap Counterparty (if any) in accordance with the "Terms and Conditions<br />
of the <strong>Note</strong>s" set out in the Base Prospectus and, where applicable, the Security Ranking Basis<br />
specified in the applicable Series Prospectus and, if applicable, the relevant ranking of the Classes<br />
within such Series; and<br />
(C) Each holder of <strong>Note</strong>s, Receipts or Coupons, by subscribing for or purchasing such <strong>Note</strong>s, Receipts or<br />
Coupons and each Swap Counterparty (if any), will be deemed to accept and acknowledge that it is<br />
fully aware that:<br />
(i) the holders of the <strong>Note</strong>s, Receipts and Coupons and the Swap Counterparty (if any) shall<br />
look solely to the sums referred to in paragraph (A), as applied in accordance with paragraph<br />
(B) above, (the Relevant Sums) for payments to be made by the Issuer in respect of the<br />
<strong>Note</strong>s, Receipts and Coupons and the Swap Agreement (if any) and the other assets (if any)<br />
of the Issuer including, in particular, assets securing other Series of <strong>Note</strong>s will not be<br />
available to make payments of any shortfall;<br />
(ii) the obligations of the Issuer to make payments in respect of the <strong>Note</strong>s, Receipts and<br />
Coupons and the Swap Agreement(s) (if any) will be limited to the Relevant Sums and the<br />
holders of the <strong>Note</strong>s, Receipts and Coupons and the Swap Counterparty (if any) shall have<br />
no further recourse to the Issuer in respect of the <strong>Note</strong>s, Receipts, Coupons and the Swap<br />
Agreement (if any), respectively;<br />
(iii) without prejudice to the foregoing, any right of the holders of the <strong>Note</strong>s, Receipts and<br />
Coupons and any Swap Counterparty to claim payment of any amount exceeding the<br />
Relevant Sums shall be automatically extinguished;<br />
(iv) the holders of the <strong>Note</strong>s, Receipts and Coupons and any Swap Counterparty shall not be able<br />
to petition for the winding-up, liquidation or bankruptcy of the Issuer or any similar<br />
insolvency related proceedings as a consequence of any such shortfall;<br />
(v) the holders of the <strong>Note</strong>s, Receipts and Coupons and any Swap Counterparty shall not be able<br />
to attach or otherwise seize the assets of the Issuer allocated to the relevant Compartment of<br />
the Issuer or other assets of the Issuer; and<br />
(vi) the obligations of the Issuer are solely the corporate obligations of the Issuer and no recourse<br />
for the payment of any obligation of the Issuer shall be had against any director, employee,<br />
officer, stockholder, affiliate, incorporator, manager or member of the Issuer.<br />
Such limitation shall be without prejudice to any claims against the relevant Issuer Credit Enhancer (if any).<br />
For the avoidance of doubt, <strong>Note</strong>s are not, and do not represent or convey any interest in a direct or indirect<br />
obligation of the obligors of the Charged Assets or of any Reference Entity or any Reference Obligations,<br />
nor do they confer on the <strong>Note</strong>holder any right (whether in respect of voting, dividend or other distributions<br />
in respect of the Charged Assets or any Reference Obligations) which the holder of any of the Charged<br />
Assets or Reference Obligations may have. The Issuer is not an agent of the <strong>Note</strong>holder for any purpose.<br />
9
The different Classes of <strong>Note</strong>s<br />
Unless otherwise specified in the applicable Series Prospectus, upon the enforcement of the security for<br />
<strong>Note</strong>s of a Series comprising more than one Class, payment of amounts due to the holders of a Class of<br />
<strong>Note</strong>s ranking senior to one or more junior ranking Class or Classes of <strong>Note</strong>s shall be made before payment<br />
is made to the next most senior ranking Class of <strong>Note</strong>s.<br />
The Trustee will generally be required to have regard to the separate interests of the holders of each Class.<br />
However, in certain circumstances the Trustee shall be required not to have regard to the interests of the<br />
holders of a Class of <strong>Note</strong>s ranking junior to one or more senior ranking Class of <strong>Note</strong>s to the extent any of<br />
such senior Class or Classes of <strong>Note</strong>s remain outstanding.<br />
No secondary market<br />
In the case of unlisted <strong>Note</strong>s in particular, no secondary market is expected to develop in respect of the <strong>Note</strong>s<br />
and, in the unlikely event that a secondary market in the <strong>Note</strong>s does develop, there can be no assurance that it<br />
will continue. Accordingly, the purchase of <strong>Note</strong>s is suitable only for investors who can bear the risks<br />
associated with a lack of liquidity in the <strong>Note</strong>s and the financial and other risks associated with an<br />
investment in the <strong>Note</strong>s.<br />
Taxation<br />
Each <strong>Note</strong>holder will assume and be solely responsible for any and all taxes of any jurisdiction or<br />
governmental or regulatory authority, including, without limitation, any state or local taxes or other like<br />
assessment or charges that may be applicable to any payment to it in respect of the <strong>Note</strong>s. The Issuer will<br />
not pay any additional amounts to <strong>Note</strong>holders to reimburse them for any tax, assessment or charge required<br />
to be withheld or deducted from payments in respect of the <strong>Note</strong>s by the Issuer or any Paying Agents.<br />
Passive Foreign Investment Company Status<br />
As the Issuer expects to be classified as a passive foreign investment company (PFIC) for U.S. federal<br />
income tax purposes, United States persons that hold <strong>Note</strong>s that are treated as equity for U.S. federal<br />
income tax purposes may suffer adverse tax consequences, including higher tax rates and potentially<br />
punitive interest charges on distributions on, and the proceeds of a sale of, the <strong>Note</strong>s.<br />
In the event that any <strong>Note</strong>s are treated as equity for U.S. federal income tax purposes, for the current year or<br />
future taxable years, United States persons that hold or beneficially own such <strong>Note</strong>s would be subject to<br />
adverse U.S. tax consequences. A PFIC determination must be made annually at the close of each taxable<br />
year and is based on, among other things, the composition of the Issuer's income and the value of the Issuer's<br />
passive assets, such as cash and cash equivalents (including cash raised in the offering), as well as the level<br />
of the Issuer's active assets in that year. See "Taxation – United States Federal Income Taxation – Tax<br />
Considerations if <strong>Note</strong>s are Characterised as Equity for U.S. Federal Income Tax Purposes - Passive<br />
Foreign Investment Company Considerations" in the Base Prospectus.<br />
Trading in the clearing systems<br />
In relation to any issue of <strong>Note</strong>s which have a minimum denomination and are tradable in the clearing<br />
systems in amounts above such minimum denomination but in multiples that are smaller than the minimum<br />
denomination, should definitive <strong>Note</strong>s be required to be issued, a holder who does not have an integral<br />
multiple of the minimum denomination (or its equivalent) in his account with the relevant clearing system at<br />
the relevant time may not receive all of his entitlement in the form of definitive <strong>Note</strong>s unless and until such<br />
time as his holding becomes an integral multiple of the minimum denomination.<br />
10
Investment Company Act<br />
Sales or transfers of <strong>Note</strong>s that would cause the Issuer to be required to register as an "investment company"<br />
under the Investment Company Act will be void and will not be honoured by the Issuer. If, at any time, a<br />
<strong>Note</strong> is held by or on behalf of a U.S. person (as defined in Regulation S) who is not an Eligible Investor at<br />
the time it purchases such <strong>Note</strong>, the Issuer may, in its discretion, redeem the <strong>Note</strong>s of any such holder who<br />
holds any <strong>Note</strong> in violation of the applicable transfer restrictions or compel any such holder to transfer the<br />
<strong>Note</strong>s to an Eligible Investor, in each case, at the expense and risk of such holder.<br />
Credit Risk<br />
A prospective purchaser of the <strong>Note</strong>s should have such knowledge and experience in financial and business<br />
matters and expertise in assessing credit risk that it is capable of evaluating the merits, risks and suitability of<br />
investing in the <strong>Note</strong>s including any credit risk associated with the Issuer, Swap Counterparty (if any), Swap<br />
Guarantor (if any), Credit Support Provider (if any) and Issuer Credit Enhancer (if any).<br />
Provision of information<br />
None of the Issuer, the Trustee, the Dealers or any affiliate makes any representation as to the credit quality<br />
of any Swap Counterparty, Swap Guarantor, Issuer Credit Enhancer, Credit Support Provider, Reference<br />
Entity or obligor of a Charged Asset or Reference Obligation. Any of such persons may have acquired, or<br />
during the term of the <strong>Note</strong>s may acquire, non-public information with respect to any Swap Counterparty,<br />
Swap Guarantor, Issuer Credit Enhancer, Credit Support Provider, Reference Entity or obligor of a Charged<br />
Asset or Reference Obligation. None of such persons is under any obligation to make such information<br />
directly available to <strong>Note</strong>holders. None of such persons is under any obligation to make available any<br />
information relating to, or keep under review on the <strong>Note</strong>holders' behalf, the business, financial conditions,<br />
prospects, creditworthiness or status of affairs of the obligors of the Charged Assets or any Reference<br />
Obligations or any Reference Entity, or conduct any investigation or due diligence into the obligors of the<br />
Charged Assets or any Reference Obligations or any Reference Entity.<br />
Business relationships<br />
The Issuer, the Dealers or any affiliate may have existing or future business relationships with any Swap<br />
Counterparty, Swap Guarantor, Issuer Credit Enhancer, Credit Support Provider, Reference Entity or obligor<br />
of a Charged Asset or Reference Obligation (including, but not limited to, lending, depository, risk<br />
management, advisory and banking relationships), and will pursue actions and take steps that they deem or it<br />
deems necessary or appropriate to protect their or its interests arising therefrom without regard to the<br />
consequences for a <strong>Note</strong>holder. In addition, the Issuer, the Dealers or any affiliate may make a market or<br />
hold positions in respect of any of the Charged Assets, Reference Entities or Reference Obligations relating<br />
to any particular transaction.<br />
Payments to third parties by Dealers<br />
In the context of an issuance of <strong>Note</strong>s, a Dealer may make payments of introduction, finding or structuring<br />
fees to third parties who may or may not be connected with the investor to whom the relevant Dealer initially<br />
sells the <strong>Note</strong>s.<br />
Legality of purchase<br />
None of the Issuer, the Trustee, the Dealers or any affiliate has or assumes responsibility for the lawfulness<br />
of the acquisition of the <strong>Note</strong>s by a prospective purchaser of the <strong>Note</strong>s, whether under the laws of the<br />
jurisdiction of its incorporation or the jurisdiction in which it operates (if different), or for compliance by that<br />
prospective purchaser with any law, regulation or regulatory policy applicable to it. However,<br />
notwithstanding the lawfulness of any acquisition of the <strong>Note</strong>s, where a <strong>Note</strong> is held by or on behalf of a<br />
U.S. person (as defined in Regulation S) who is not an Eligible Investor at the time it purchases such <strong>Note</strong>,<br />
the Issuer may, in its discretion, redeem the <strong>Note</strong>s of any such holder who holds any <strong>Note</strong> in violation of the<br />
11
application transfer restrictions or compel any such holder to transfer the <strong>Note</strong>s to an Eligible Investor, in<br />
each case, at the expense and risk of such holder.<br />
Independent review and advice<br />
Each prospective purchaser of <strong>Note</strong>s must determine, based on its own independent review and such<br />
professional advice as it deems appropriate under the circumstances, that its acquisition of the <strong>Note</strong>s (i) is<br />
fully consistent with its (or if it is acquiring the <strong>Note</strong>s in a fiduciary capacity, the beneficiary's) financial<br />
needs, objectives and condition, (ii) complies and is fully consistent with all investment policies, guidelines<br />
and restrictions applicable to it (whether acquiring the <strong>Note</strong>s as principal or in a fiduciary capacity) and (iii)<br />
is a fit, proper and suitable investment for it (or if it is acquiring the <strong>Note</strong>s in a fiduciary capacity, for the<br />
beneficiary), notwithstanding the clear and substantial risks inherent in investing in or holding the <strong>Note</strong>s.<br />
No reliance<br />
A prospective purchaser may not rely on the Issuer, the Trustee, the Dealers or any affiliate in connection<br />
with its determination as to the legality of its acquisition of the <strong>Note</strong>s or as to the other matters referred to<br />
above.<br />
Enforcement of legal liabilities<br />
The Issuer is incorporated under the laws of the Grand Duchy of Luxembourg. All of the directors of the<br />
Issuer under this <strong>Programme</strong> reside, and substantially all of the assets of the Issuer are, located outside the<br />
United States. It may not be possible to enforce, in original actions in Luxembourg courts, liabilities<br />
predicated solely on the U.S. federal securities laws.<br />
12
Documents Incorporated by Reference<br />
The following documents which have been previously published and have been filed with the Irish Stock<br />
Exchange shall be deemed to be incorporated in, and form part of, this Issuer Addendum:<br />
· the annual financial statements of Ashwell Rated for the financial year ended 10 October 2005;<br />
· the annual financial statements of Ashwell Rated for the financial year ended 10 October 2006; and<br />
· pages 1 to 194 (inclusive) of the Base Prospectus dated 22 November 2007 in relation to the <strong>Programme</strong>.<br />
The information on pages 195 to 216 (inclusive) of the Base Prospectus dated 22 November 2007 in relation<br />
to the <strong>Programme</strong> is not relevant to the investor.<br />
13
General<br />
Ashwell Rated S.A.<br />
Ashwell Rated S.A. (Ashwell Rated) is a securitisation company (société de titrisation) incorporated under<br />
the laws of the Grand Duchy of Luxembourg on 17 May 2005 as a public limited liability company (société<br />
anonyme) with an unlimited duration. Ashwell Rated is a special purpose entity incorporated, amongst other<br />
things, for the purpose of issuing asset backed securities. Copies of its articles of incorporation were lodged<br />
with the Luxembourg trade and companies register on 18 May 2005. The registration number of Ashwell<br />
Rated is B.107.848. Ashwell Rated's articles of incorporation are published in the "Mémorial, Recueil des<br />
Sociétés et Associations, Luxembourg" number 947 dated 27 September 2005 on page 45436. The registered<br />
office of Ashwell Rated is Carré Bonn, 20, rue de la Poste, L-2346 Luxembourg and its telephone number is<br />
(+352) 47 23 23.<br />
Share Capital and Shareholders<br />
The shares in Ashwell Rated are held by Luxembourg Corporation Company S.A. and The Structured<br />
Charitable Trust (together, the Share Trustees) under the terms of a declaration of trust under which the<br />
Share Trustees hold the shares on trust for charitable and heritage bodies. The Issuer is directly owned and<br />
controlled by these parties. Luxembourg Corporation Company S.A. was incorporated under the laws of the<br />
Grand Duchy of Luxembourg as a public limited liability company (société anonyme). The Structured<br />
Charitable Trust is a charitable trust company incorporated under the laws of Jersey. The Share Trustees will<br />
apply any income derived by them from Ashwell Rated solely for charitable purposes.<br />
The financial year of Ashwell Rated commences on 11 October in each year and ends on 10 October of the<br />
following year. The annual general meeting of the shareholders of Ashwell Rated is held on 16 March of<br />
each year at 10.00 a.m. in Luxembourg at the registered office of Ashwell Rated.<br />
The subscribed share capital of Ashwell Rated is €31,<strong>000</strong> (thirty one thousand euro) consisting of 62 (sixty<br />
two) shares in registered form (actions nominatives) with a par value of <strong>€5</strong>00 each.<br />
Financial Statements<br />
In accordance with article 75 of the Luxembourg act dated 10 August 1915 on commercial companies, as<br />
amended (the Companies Act 1915) Ashwell Rated is obliged to publish its accounts on an annual basis<br />
within one month after their approval, by and following the requisite holding of the annual general meeting<br />
of the shareholders of Ashwell Rated. Since 17 May 2005, Ashwell Rated has not carried out any business<br />
other than entering into transactions in respect of the issue of <strong>Note</strong>s and has not entered into operations other<br />
than that of a purely administrative nature. Financial statements as of 10 October 2005 and 10 October 2006<br />
have been approved and published.<br />
Principal Activities<br />
The corporate objects of Ashwell Rated are to enter into, perform and serve as a vehicle for, any<br />
securitisation transactions as permitted under the Securitisation Act 2004. To that effect, Ashwell Rated may,<br />
inter alia, acquire or assume, directly or through another entity or vehicle, the risks relating to the holding or<br />
property of claims, receivables and/or other goods or assets (including securities of any kind), either movable<br />
or immovable, tangible or intangible, and/or risks relating to liabilities or commitments of third parties or<br />
which are inherent to all or part of the activities undertaken by third parties, by issuing securities of any kind<br />
whose value or return is linked to these risks.<br />
Ashwell Rated may assume or acquire these risks by acquiring, by any means, the claims, receivables and/or<br />
assets, by guaranteeing the liabilities or commitments or by binding itself by any other means.<br />
14
Ashwell Rated may proceed to (i) the acquisition, holding and disposal, in any form, by any means, whether<br />
directly or indirectly, of participations, rights and interests in, and obligations of, Luxembourg and foreign<br />
companies, (ii) the acquisition by purchase, subscription, or in any other manner, as well as the transfer by<br />
sale, exchange or in any other manner of stock, bonds, debentures, notes and other securities or financial<br />
instruments of any kind (including notes or parts or units issued by Luxembourg or foreign mutual funds or<br />
similar undertakings) and agreements or contracts relating thereto, and (iii) the ownership, administration,<br />
development and management of a portfolio (including, among other things, the assets referred to in (i) and<br />
(ii) above). It may further acquire, hold and dispose of interests in partnerships, limited partnerships, trusts,<br />
funds and other entities.<br />
Ashwell Rated may borrow in any form. It may issue notes, bonds, debentures, certificates, shares,<br />
beneficiary parts, warrants and any kind of debt or equity including under one or more issue programmes. It<br />
may lend funds including the proceeds of any borrowings and/or issues of securities to its subsidiaries,<br />
affiliated companies or to any other company.<br />
In accordance with, and to the extent permitted by, the Securitisation Act 2004, Ashwell Rated may also give<br />
guarantees and grant security over its assets in order to secure the obligations it has assumed for the<br />
securitisation of these assets or for the benefit of investors (including their trustee or representative, if any)<br />
and/or any issuing entity participating in a securitisation transaction of Ashwell Rated. It may not pledge,<br />
transfer, encumber or otherwise create security over some or all of its assets, unless permitted by the<br />
Securitisation Act 2004.<br />
Ashwell Rated may enter into, execute and deliver and perform any swaps, futures, forwards, derivatives,<br />
options, repurchase, stock lending and similar transactions. It may generally employ any techniques and<br />
instruments relating to investments for the purpose of their efficient management, including, but not limited<br />
to, techniques and instruments designed to protect it against credit, currency exchange, interest rate risks and<br />
other risks.<br />
The descriptions above are to be understood in their broadest sense and their enumeration is not limiting. The<br />
corporate objects shall include any transaction or agreement which is entered into by Ashwell Rated,<br />
provided it is not inconsistent with the foregoing enumerated objects.<br />
In general, Ashwell Rated may take any controlling and supervisory measures and carry out any operation or<br />
transaction which it considers necessary or useful in the accomplishment and development of its corporate<br />
objects, to the largest extent permitted under the Securitisation Act 2004.<br />
In accordance with the Securitisation Act 2004, the board of directors of Ashwell Rated is entitled to create<br />
one or more compartments (representing the assets of Ashwell Rated attributable to an issue of securities)<br />
corresponding each to a separate part of Ashwell Rated's estate.<br />
Auditors<br />
The external auditors (réviseurs d'entreprises) of Ashwell Rated are Deloitte S.A., whose registered office is<br />
at 560, rue de Neudorf, L-2220 Luxembourg, Grand Duchy of Luxembourg. Deloitte S.A. is a member of<br />
the Institut des Réviseurs d'Entreprises, which is the equivalent of the Institute of Chartered Accountants in<br />
the United Kingdom.<br />
Administrative, Management and Supervisory Bodies<br />
Ashwell Rated is managed by its board of directors composed of:<br />
1. Mr Doeke van der Molen, employee, whose business address is at Carré Bonn, 20, rue de la<br />
Poste, L-2346 Luxembourg;<br />
15
2. Ms Cândida Gillespie, employee, whose business address is at Carré Bonn, 20, rue de la<br />
Poste, L-2346 Luxembourg; and<br />
3. Mr Paul Lefering, employee, whose business address is at Carré Bonn, 20, rue de la Poste,<br />
L-2346 Luxembourg,<br />
(each a Director and together the Directors).<br />
Mr Doeke van der Molen has been appointed by the board of directors of the Issuer as<br />
chairman of the board of directors of the Issuer.<br />
No conflict exists between the duties of the Directors and the private interest of any Director.<br />
As a public limited liability company (société anonyme), Ashwell Rated must have at least three directors at<br />
all times. In the event that a director resigns but there are still three or more directors remaining in office,<br />
there is no requirement for any immediate action to be taken. A new director can then be appointed at the<br />
next general meeting (either annual or extraordinary) of the shareholders of Ashwell Rated.<br />
If a director resigns and this reduces the number of directors to less than three, a new director must be<br />
appointed so that there are at least three directors. The new director may be appointed either by: (i) an<br />
extraordinary general meeting of the shareholders of Ashwell Rated specifically convened to vote on the<br />
appointment of a new director; or (ii) the remaining directors, on a provisional basis. A director<br />
provisionally appointed by the remaining directors must have its appointment confirmed at the next general<br />
meeting (either annual or extraordinary) of the shareholders of Ashwell Rated.<br />
16
1. Authorisation<br />
GENERAL INFORMATION<br />
The Issuer has obtained all necessary consents, approvals and authorisations in connection with the<br />
issue and performance of the <strong>Note</strong>s to be issued by it. The update of the <strong>Programme</strong> was duly<br />
authorised by a resolution of the Board of Directors of Ashwell Rated dated on or about<br />
21 November 2007.<br />
2. Significant or Material Change<br />
There has been no material adverse change in the financial or trading position or prospects of<br />
Ashwell Rated since the date of its last published audited financial statements.<br />
3. Legal and Arbitration Proceedings<br />
There are no governmental, legal or arbitration proceedings (including any such proceedings which<br />
are pending or threatened of which the Issuer is aware) which may have or have had since the date of<br />
its incorporation a significant effect on the financial position or profitability of the Issuer.<br />
4. Annual Accounts<br />
In accordance with article 75 of the Companies Act 1915 Ashwell Rated is obliged to publish its<br />
accounts on an annual basis within one month after their approval, by and following the requisite<br />
holding of the annual general meeting of the shareholders.<br />
The most recently published and future annual accounts of Ashwell Rated will be available from the<br />
Specified Office of the Paying Agents in London and Ireland.<br />
5. Listing of <strong>Note</strong>s on the Irish Stock Exchange<br />
The listing of the <strong>Note</strong>s on the Irish Stock Exchange will be expressed at their nominal amount<br />
(excluding accrued interest). It is expected that each Tranche of <strong>Note</strong>s which is to be admitted to the<br />
regulated market of the Irish Stock Exchange will be admitted separately as and when issued. The<br />
approval of the Base Prospectus in respect of the <strong>Note</strong>s is expected to be granted on or before<br />
22 November 2007.<br />
6. Documents on Display<br />
For the life of the <strong>Note</strong>s copies of the following documents (in English) will, when published, be<br />
available for inspection in electronic form free of charge during usual business hours on any<br />
weekday (Saturdays, Sundays and public holidays excepted) from the registered office of the Issuer<br />
and from the specified office of each of the Paying Agents for the time being in London and Ireland:<br />
(i) the articles of incorporation of the Issuer;<br />
(ii) the most recently published audited annual financial statements of the Issuer;<br />
(iii) the Master Trust Deed (which includes the forms of the Global <strong>Note</strong>s, the Definitive <strong>Note</strong>s,<br />
the Receipts, the Coupons, the Talons and the Registered <strong>Note</strong>s), the Deed of Adherence, the<br />
Agency Agreement, the <strong>Programme</strong> Agreement, the Custodial Services Agreement and the<br />
Put Option Agreement;<br />
(iv) any supplements to the documents referred to in (iii) above which relate to a particular issue<br />
of <strong>Note</strong>s and the Charged Agreements, any Charging Documents, any Credit Support<br />
17
Documents and any <strong>Note</strong>s Guarantee relating to a particular issue of <strong>Note</strong>s (save that such<br />
documents relating to an unlisted issue of <strong>Note</strong>s will only be available for inspection by a<br />
holder of such <strong>Note</strong> and such holder must produce evidence satisfactory to the Issuer or to<br />
the relevant Paying Agent, as the case may be, as to the identity of such holder);<br />
(v) a copy of the Base Prospectus;<br />
(vi) when published, any Summary and any Series Prospectus (save that such documents relating<br />
to a <strong>Note</strong> which is neither admitted to trading on a regulated market in the European<br />
Economic Area or offered in the European Economic Area in circumstances where a<br />
prospectus is required to be published under the Prospectus Directive will only be available<br />
for inspection by a holder of such <strong>Note</strong> and such holder must produce evidence satisfactory<br />
to the Issuer or to the relevant Paying Agent, as the case may be, as to the identity of such<br />
holder); and<br />
(vii) in the case of each issue of listed <strong>Note</strong>s subscribed pursuant to a subscription agreement, the<br />
subscription agreement (or equivalent document).<br />
7. U.S. Tax Legend<br />
Each <strong>Note</strong> in bearer form which has an original maturity of more than one year and all Receipts,<br />
Coupons and Talons relating to such <strong>Note</strong>s will bear the following legend: "Any United States<br />
person who holds this obligation will be subject to limitations under the United States income tax<br />
laws, including the limitations provided in Sections 165(j) and 1287(a) of the Internal Revenue<br />
Code".<br />
8. Clearing Systems<br />
The <strong>Note</strong>s (other than those in definitive form) may be accepted for clearance through Euroclear or<br />
Clearstream, Luxembourg (which are the entities in charge of keeping the records) (in each case as<br />
specified in the applicable Series Prospectus). The appropriate Common Code and ISIN for each<br />
Tranche allocated by Euroclear or Clearstream, Luxembourg, will be specified in the applicable<br />
Series Prospectus. If the <strong>Note</strong>s are to clear through an additional or alternative clearing system the<br />
appropriate information will be specified in the applicable Series Prospectus.<br />
The address of Euroclear is Euroclear Bank S.A./N.V., 1 Boulevard du Roi Albert II, B-1210<br />
Brussels and the address of Clearstream, Luxembourg is Clearstream Banking, 42, Avenue J.F.<br />
Kennedy, L-1855 Luxembourg.<br />
9. Conditions for Determining Price<br />
The price and amount of <strong>Note</strong>s to be issued under the <strong>Programme</strong> will be determined by the Issuer<br />
and the relevant Dealer at the time of issue in accordance with prevailing market conditions.<br />
10. Restricted <strong>Note</strong>s<br />
So long as any of the <strong>Note</strong>s are "restricted <strong>Note</strong>s" within the meaning of Rule 144(a)(3) under the<br />
Securities Act, the Issuer will, unless it becomes subject to and complies with the reporting<br />
requirements of Section 13 or 15(d) of the Exchange Act or the information furnishing requirements<br />
of Rule 12g3-2(b) thereunder, provide to any holder or beneficial owner of <strong>Note</strong>s that are restricted<br />
<strong>Note</strong>s, or to any prospective purchaser of <strong>Note</strong>s that are restricted <strong>Note</strong>s designated by a holder or<br />
beneficial owner, upon the request of such holder, beneficial owner or prospective purchaser, the<br />
information required to be provided by Rule 144A(d)(4) under the Securities Act.<br />
18
11. External Auditors<br />
The external auditors (réviseur d'entreprises) of Ashwell Rated are Deloitte S.A., whose registered<br />
office is at 560, rue de Neudorf, L-2220 Luxembourg. Deloitte S.A. is a member of the Institut des<br />
Réviseurs d'Entreprises (Luxembourg institute of auditors).<br />
12. Post-Issuance Information<br />
The Issuer does not intend to provide any post-issuance information in relation to any Series of<br />
<strong>Note</strong>s or the performance of any Charged Assets or Reference Obligations.<br />
19
REGISTERED OFFICES OF<br />
THE ISSUER<br />
Ashwell Rated S.A.<br />
Carré Bonn, 20, rue de la Poste<br />
L-2346 Luxembourg<br />
PRINCIPAL PAYING AGENT, AGENT BANK AND TRANSFER AGENT<br />
Citibank, N.A.<br />
21st Floor Citigroup Centre<br />
Canada Square<br />
Canary Wharf<br />
London E14 5LB<br />
EUROPEAN REGISTRAR<br />
Citigroup Global Markets Deutschland AG & Co. KGaA<br />
German Agency and Trust Department<br />
Reuterweg 16<br />
60323 Frankfurt am Main<br />
Germany<br />
NEW YORK REGISTRAR<br />
Citibank, N.A.<br />
Citibank Agency & Trust Services<br />
14th Floor<br />
111 Wall Street<br />
New York 1<strong>000</strong>5<br />
U.S.A<br />
IRISH PAYING AGENT AND TRANSFER AGENT<br />
Citibank International plc<br />
1 North Wall Quay<br />
Dublin 1<br />
Ireland<br />
TRUSTEE<br />
Citicorp Trustee Company <strong>Limited</strong><br />
Citigroup Centre<br />
Canada Square<br />
Canary Wharf<br />
London E14 5LB<br />
20
To the Dealers and the Trustee<br />
as to English law:<br />
Simmons & Simmons<br />
One Ropemaker Street<br />
London EC2Y 9SS<br />
AUDITORS<br />
To Ashwell Rated S.A.<br />
Deloitte S.A.<br />
560, rue de Neudorf,<br />
L-2220 Luxembourg<br />
Grand Duchy of Luxembourg<br />
LEGAL ADVISERS<br />
To the Dealers as to U.S. law:<br />
Simmons & Simmons<br />
One Ropemaker Street<br />
London EC2Y 9SS<br />
IRISH LISTING AGENT<br />
A&L Listing <strong>Limited</strong><br />
International Financial Services Centre<br />
North Wall Quay<br />
Dublin 1<br />
21<br />
To the Dealers and the Trustee<br />
as to Luxembourg law:<br />
Allen & Overy Luxembourg<br />
58, rue Charles Martel<br />
L-2134 Luxembourg